Recurrent Small Cell Lung Cancer (SCLC) Completed Phase 2 Trials for Carboplatin (DB00958)

Also known as: Recurrent Small-cell Lung Cancer (SCLC) / Recurrent Small Cell Lung Cancer / Refractory Small cell lung cancer / Small Cell Lung Cancer Recurrent

IndicationStatusPhase
DBCOND0122754 (Recurrent Small Cell Lung Cancer (SCLC))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00042978Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung CancerTreatment